Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Could Codeine Containing OTC Analgesics Sold in Romania ..., Slides of Medicine

Results: The results show that codeine can be very easily separated from NSAID as aspirin, acetaminophen, ibuprofen using the cold water.

Typology: Slides

2021/2022

Uploaded on 09/27/2022

jennyfromtheblock
jennyfromtheblock 🇬🇧

2.3

(3)

225 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
RESEARCH ARTICLE
Acta Medica Marisiensis 2016;62(3):309-312 DOI: 10.1515/amma-2016-0031
Could Codeine Containing OTC Analgesics Sold in
Romania be Used as Recreational Drugs?
Croitoru Mircea Dumitru, Fogarasi Erzsébet*, Varga Erzsébet, Chelaru Adelina, Căliman Monica-Simina,
Fülöp Ibolya
University of Medicine and Pharmacy Tirgu Mures, Romania
Objective: Analgesic medicines containing combinations of nonsteroidal anti-inflammatory drugs and codeine are available without prescrip-
tion. Codeine, in these combinations can not be used recreationally due to the high toxicity profile of the nonsteroidal anti-inflammatory drugs.
However, methods for extracting codeine from these types of medication are available on the internet. The purpose of this work is to evaluate
if codeine can be extracted from codeine containing analgesics sold without prescription.
Methods: High Performance Liquid Chromatography (HPLC) with UV detection was used to measure the amounts of codeine and nonste-
roidal anti-inflammatory drugs recovered after applying an extraction method described on the internet.
Results: The results show that codeine can be very easily separated from NSAID as aspirin, acetaminophen, ibuprofen using the cold water
extraction method. However, very large differences (20 to 90%) were recorded for the recovery of codeine depending on the OTC product
that was used. That large difference increases the risk of potentially lethal overdoses when the user switches between “similar” products.
Conclusions: Our work shows that analgesic medication with codeine content can be recreationally used after the extraction of codeine. In
order to prevent this, the sell of this type of products should be regulated or products that do not allow the extraction of codeine should be
developed.
Keywords: codeine, recreational drugs, cold water extraction, HPLC
Received: 28 July 2016 / Accepted: 13 September 2016
Introduction
Pain is a serious disabling condition often associated with
worsening of the health condition. People in pain may
experience greater functional impairment, depression, de-
creased appetite, impaired sleep, social isolation than the
persons that do not experience pain [1]. Pain management
is considered an ethical issue due to the significant discom-
fort that is produced to the individual experiencing it and
every available measure should be taken in order to allevi-
ate pain, regardless that is chronic or acute in nature [2,3].
Most of the time, pain is the sign of an illness and fades
when efficient treatment is used. There are however cases,
when the health condition of the individual cannot be im-
proved or when the cause of the pain is not known as in the
case of many migraines. In such conditions, the only treat-
ment available are the substances able to reduce the ability
of an organism to feel pain: analgesics. There are analgesics
as non steroidal anti-inflammatory drugs (NSAID) and
opioids designed to reduce sensation of pain, but nowa-
days, even substances that were not designed as analgesics
(carbamazepine, antidepressant medication, etc) are some-
times tried [4,5].
One of the most efficient pain medications, used for
moderate to high intensity pain, are the opioids. Unfor-
tunate, even if efficient pain control can be attained, these
substances are prone to induce fearsome psychological and
physical addiction, effect that excludes their use as OTC
medication [6]. Another option to reduce pain intensity
are the NSAIDs, but these substances are also known to
have negative health effects (risk of myocardial infarction,
stroke, gastric bleeding, kidney failure, etc.) especially
when used in high doses for a long time. Due to the lack
of addictive properties, the NSAIDs with low toxicity pro-
file as acetylsalicylic acid, acetaminophen, ibuprofen, etc
are available as OTC pain medication. Combinations of
opioids and NSAIDs are, however, sold in most countries
worldwide as OTC pain medication. This combination has
the advantage of dosage reduction of both components and
high efficiency in reducing low intensity pain. The dosage
reduction greatly increases the safety of the combinations
since the toxicity of opioids and NSAIDs is not overlap-
ping. The presence of the NSAIDs, with high acute toxic-
ity in large doses, prevents the user to increase the dosage
until the recreational dose of the opioid is attained (it is
well known that the recreational dose of an opioid is sig-
nificantly larger than its analgesic dose) [7-9].
The opioid of choice for OTC analgesic combinations is
codeine phosphate, while the NSAID of choice is acetami-
nophen. The NSAID to codeine ratio is too high for a rec-
reational use in these products. However, drug users take
advantage of the low cold water solubility of the NSAID
compared with that of codeine phosphate in order to sepa-
rate the codeine from the NSAID. This way, extracted co-
deine can be recreationally used without the limitations
brought by the significant NSAID’s toxicity in high doses.
The extraction method described in detail on several inter-
net forums (named CWE from cold water extraction) is
* Correspondence to: Erzsébet Fogarasi
E-mail: fogarasi.erzsebet@umftgm.ro
pf3
pf4

Partial preview of the text

Download Could Codeine Containing OTC Analgesics Sold in Romania ... and more Slides Medicine in PDF only on Docsity!

RESEARCH ARTICLE

Acta Medica Marisiensis 2016;62(3):309-312 (^) DOI: 10.1515/amma-2016-

Could Codeine Containing OTC Analgesics Sold in

Romania be Used as Recreational Drugs?

Croitoru Mircea Dumitru, Fogarasi Erzsébet*, Varga Erzsébet, Chelaru Adelina, Căliman Monica-Simina, Fülöp Ibolya

University of Medicine and Pharmacy Tirgu Mures, Romania

Objective: Analgesic medicines containing combinations of nonsteroidal anti-inflammatory drugs and codeine are available without prescrip- tion. Codeine, in these combinations can not be used recreationally due to the high toxicity profile of the nonsteroidal anti-inflammatory drugs. However, methods for extracting codeine from these types of medication are available on the internet. The purpose of this work is to evaluate if codeine can be extracted from codeine containing analgesics sold without prescription. Methods: High Performance Liquid Chromatography (HPLC) with UV detection was used to measure the amounts of codeine and nonste- roidal anti-inflammatory drugs recovered after applying an extraction method described on the internet. Results: The results show that codeine can be very easily separated from NSAID as aspirin, acetaminophen, ibuprofen using the cold water extraction method. However, very large differences (20 to 90%) were recorded for the recovery of codeine depending on the OTC product that was used. That large difference increases the risk of potentially lethal overdoses when the user switches between “similar” products. Conclusions: Our work shows that analgesic medication with codeine content can be recreationally used after the extraction of codeine. In order to prevent this, the sell of this type of products should be regulated or products that do not allow the extraction of codeine should be developed.

Keywords: codeine, recreational drugs, cold water extraction, HPLC

Received: 28 July 2016 / Accepted: 13 September 2016

Introduction Pain is a serious disabling condition often associated with worsening of the health condition. People in pain may experience greater functional impairment, depression, de- creased appetite, impaired sleep, social isolation than the persons that do not experience pain [1]. Pain management is considered an ethical issue due to the significant discom- fort that is produced to the individual experiencing it and every available measure should be taken in order to allevi- ate pain, regardless that is chronic or acute in nature [2,3]. Most of the time, pain is the sign of an illness and fades when efficient treatment is used. There are however cases, when the health condition of the individual cannot be im- proved or when the cause of the pain is not known as in the case of many migraines. In such conditions, the only treat- ment available are the substances able to reduce the ability of an organism to feel pain: analgesics. There are analgesics as non steroidal anti-inflammatory drugs (NSAID) and opioids designed to reduce sensation of pain, but nowa- days, even substances that were not designed as analgesics (carbamazepine, antidepressant medication, etc) are some- times tried [4,5]. One of the most efficient pain medications, used for moderate to high intensity pain, are the opioids. Unfor- tunate, even if efficient pain control can be attained, these substances are prone to induce fearsome psychological and physical addiction, effect that excludes their use as OTC

medication [6]. Another option to reduce pain intensity are the NSAIDs, but these substances are also known to have negative health effects (risk of myocardial infarction, stroke, gastric bleeding, kidney failure, etc.) especially when used in high doses for a long time. Due to the lack of addictive properties, the NSAIDs with low toxicity pro- file as acetylsalicylic acid, acetaminophen, ibuprofen, etc are available as OTC pain medication. Combinations of opioids and NSAIDs are, however, sold in most countries worldwide as OTC pain medication. This combination has the advantage of dosage reduction of both components and high efficiency in reducing low intensity pain. The dosage reduction greatly increases the safety of the combinations since the toxicity of opioids and NSAIDs is not overlap- ping. The presence of the NSAIDs, with high acute toxic- ity in large doses, prevents the user to increase the dosage until the recreational dose of the opioid is attained (it is well known that the recreational dose of an opioid is sig- nificantly larger than its analgesic dose) [7-9]. The opioid of choice for OTC analgesic combinations is codeine phosphate, while the NSAID of choice is acetami- nophen. The NSAID to codeine ratio is too high for a rec- reational use in these products. However, drug users take advantage of the low cold water solubility of the NSAID compared with that of codeine phosphate in order to sepa- rate the codeine from the NSAID. This way, extracted co- deine can be recreationally used without the limitations brought by the significant NSAID’s toxicity in high doses. The extraction method described in detail on several inter- net forums (named CWE from cold water extraction) is

  • Correspondence to: Erzsébet Fogarasi E-mail: fogarasi.erzsebet@umftgm.ro

extremely easy to apply by anyone without any chemistry background and requires only a regular freezer and a coffee filter [10-15]. The purpose of this work is to check if the CWE meth- od described on the internet forums is usable to extract codeine from the OTC products sold in Romania and to evaluate the risks involved by such practice.

Materials and methods Materials : all common chemicals and reagents (acetonitrile, methanol, anhydrous Na 2 HPO 4 , H 2 SO4 96%, H 3 PO 4 85%) were purchased from local providers and were used without any further purification. Codeine, caffeine, aceta- minophen, salicylic acid and ibuprofen were of pharma- ceutical quality. Ultra-pure water was obtained using a Mili-Q purification system (Milipore Corporation, USA). The following pharmaceutical products were purchased from pharmacies: Fasconal (Gedeon Richter Romania SA, Romania), Aspaco (SC Bioeel SRL, Romania), Codamin P (Terapia SA, Romania), Solpadeine (GlaxoSmithKn- line, Ireland), Nurofen Plus (Reckitt Benckiser Healthcare International Limited, Great Britain), Tusocalm (Arena Group SA, Romania), Ultracod (Zentiva KS, Czech Re- public). Coffee filter no 2 and no 4 were purchased from a local supermarket. Apparatus : High Performance Liquid Chromatography (HPLC) analysis was carried out on a Merck HPLC system consisted of: quaternary pump Merck Hitachi L-7100, auto sampler Merck Hitachi L-7200, column thermostat Merck Hitachi L-7360, DAD detector Merck Hitachi L-7455, interface Merck Hitachi L-7000, solvent degasser Merck Hitachi L-7612, software D-7000 HSM-Manager, LichroCART 250-4, Rp-Select B (5μm) column, Merck KgaA, Germany. Methods :

  • HPLC method: mobile phase consisted in: 20 mM pho- sphate buffer brought to pH=2.5 with phosphoric acid (A) and acetonitrile (B); the gradient elution program is shown in table I: injection volume 100μl using the loop method; DAD domain 190-400nm with the extraction of the best chromatogram at 205nm.
  • CWE method: 10 tablets were grinded in a mortar, the powder was brought in a graduated cylinder and purified water was added up to 100 ml, followed by mixing and ultrasonication. The suspensions were then placed in a freezer and when the first crystals of ice were formed, were filtered through the coffee filters no 2 and 4. Soluti- ons were diluted 1:1000, filtered through an HPLC ny- lon filter (0.45μm) and injected into the HPLC system.

Results Performance of the analytical method Specificity Standard blanks (also called placebo by the pharmaceuti- cal industry) could not be obtained. Large variation in the type of the NSAID that was used in these combinations together with the high similarity in the auxiliary substances present in the products allowed us to use one product as blank for the other products. For example Nurofen Plus that contains ibuprofen as NSAID could be used as blank for all other NSAIDs used in the tested products. No in- terferences of the blanks were observed in this study. Chro- matograms for the standard solutions and for Fasconal are shown in figures 1 and 2, respectively.

Linearity Calibration curves were prepared for all tested substances in the range of 0.1-10μg/ml (N=3, average value was used for

Table I. Gradient elution program Time (min) A (%) B (%) Flow (ml/min) 0.0 85 15 1. 4.0 85 15 1. 9.0 30 70 1. 12.0 30 70 1. 12.1 85 15 1. 14.0 85 15 1.

0 2 4 6 8 10 12 14

Absorbance units (AU)

Time (min)

Acetaminophen

Codeine (^) Caffeine

Acetylsalicylic acid

Salicylic acid

Ibuprofen

Fig. 1. Chromatogram of the standard solution (10 μg/ml)

0 2 4 6 8 10 12 14

Absorbance (AU)

Time (min)

Acetaminophen

Codeine Caffeine

Acetylsalicylic acid

Salicylic acid

Fig. 2. Chromatogram of cold water extracted and diluted 1: Fasconal

Acknowledgement The research was supported by the University of Medicine and Pharmacy of Tîrgu Mureș and Gedeon Richter Roma- nia SA, internal research grant number 15221/02.11.2015.

Conflicts of interest The authors report no conflicts of interest.

References

  1. Malec M, Shega JW. Pain Management in the Elderly. Med Clin North Am. 2015;99(2):337-350. doi: 10.1016/j.mcna.2014.11.007.
  2. Pappagallo M, Heinberg LJ. Ethical issues in the management of chronic nonmalignant pain. Semin Neurol. 1997;17:203-211.
  3. Lome B. Acute pain and the critically ill trauma patient. Crit Care Nurs Q. 2005;28:200-207.
  4. Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016; doi: 10.1002/14651858.CD005220.pub2.
  5. Buescher JJ. Carbamazepine for Acute and Chronic Pain. Am Fam Physician. 2006;73:1549-1550. doi: 10.1002/14651858.CD005451.
  6. Huber E, Robinson RC, Noe CE, Van Ness O. Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk. Healthcare (Basel). 2016;4(2). doi: 10.3390/healthcare4020029.
  7. Sweetman SC (ed): Martindale, The Complete Drug Reference. London. Pharmaceutical Press. 2009. 8. Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;(9):CD008659. 9. Pfaffenrath V, Diener HC, Pageler L, Peil H, Aicher B. OTC analgesics in headache treatment: open-label phase vs randomized double-blind phase of a large clinical trial. Headache. 2009;49:638-645. 10. Nielsen S, Van Hout MC. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between. Curr Top Behav Neurosci. 2016. doi: 10.1007/7854_2015_422. 11. Hamer AM, Spark MJ, Wood PJ, Roberts E. The upscheduling of combination analgesics containing codeine: the impact on the practice of pharmacists. Res Social Adm Pharm. 2014;10:669-678. doi: 10.1016/j. sapharm.2013.08.004. 12. Van Hout MC, Norman I. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies. Int J Drug Policy. 2016;27:17-22. doi: 10.1016/j. drugpo.2015.09.007. 13. Barkin RL. Acetaminophen, aspirin, or Ibuprofen in combination analgesic products. Am J Ther. 2001;8:433-442. 14. *** Cold Water Extraction of Opioids available at: https://drugs-forum. com/forum/showwiki.php?title=Cold_Water_Extraction_of_Opioids, accessed on 15.06.2016. 15. Van Hout MC. Nod and wave: an Internet study of the codeine intoxication phenomenon. Int J Drug Policy. 2015;26:67-77. doi: http:// dx.doi.org/10.1016/j.drugpo.2014.06.016. 16. Alves EA, Soares JX, Afonso CM, et al. The harmful chemistry behind “krokodil”: Street-like synthesis and product analysis. Forensic Sci Int. 2015;257:76-82. doi: 10.1016/j.forsciint.2015.07.042.